CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Check out our top picks below. If you are looking for a powerful allergy nasal spray that provides 24-hour all-in-one relief for even your worst seasonal, year-round, indoor, and outdoor allergy ...

Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased acute feelings of loneliness, even months after treatment.

Often, nasal sprays can provide faster relief than oral medication ... ketorolac (Toradol), an NSAID available as a nasal spray, to help manage migraine attacks that cause severe pain.

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...